Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin cardioplegia in CABG surgery
IRCT20211225053517N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in coronary arteriosclerosis and myocardial ischemia-reperfusion injury comparing Nitroglycerin cardioplegia with Placebo cardioplegia (2 arms). Primary endpoints: Perioperative myocardial ischemia-reperfusion injury, Serum troponin I change and 2 more. Started Sep 2021; status: completed.
02
Drugs
nitroglycerin
03
Conditions
coronary arteriosclerosismyocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on IRCT20211225053517N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211225053517N1.